You May Have Missed: JPMorgan Chase & Co. (JPM), Yelp Inc (YELP), Amarin Corporation plc (ADR) (AMRN) & More

Amarin Corporation plc (ADR) (NASDAQ:AMRN) : Amarin Announces Approval of Supplemental New Drug Application for BASF as Additional Vascepa(R) Active Pharmaceutical Ingredient Supplier (4-Traders)
Amarin Corporation plc (ADR) (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today the approval of the Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for BASF as an additional Vascepa® (icosapent ethyl) active pharmaceutical ingredient (API) supplier. …Along with this planned qualification of additional API suppliers, Amarin Corporation plc (ADR) (NASDAQ:AMRN)’s significant progress includes expansion of patent protection for Vascepa in the United States with 19 Amarin Corporation plc (ADR) (NASDAQ:AMRN) patents either issued or allowed and over 30 additional patent applications being prosecuted. Amarin is also pursuing patent applications related to Vascepa in multiple jurisdictions outside the United States. In addition, Amarin Corporation plc (ADR) (NASDAQ:AMRN) has plans for the submission of a fourth planned supplier in 2013.

athenahealth, Inc. Reports First Quarter Fiscal Year 2013 Results (WSJ)
athenahealth, Inc (NASDAQ:ATHN) (the “Company,” “we,” or “athenahealth”), a leading provider of cloud-based electronic health record (EHR), practice management, and care coordination services to medical groups and health systems, today announced financial and operational results for the first quarter of fiscal year 2013. The Company will conduct a conference call tomorrow May 3, 2013, at 8:30 a.m. Eastern Time to discuss these results and management’s outlook for future financial and operational performance. Total revenue for the three months ended March 31, 2013, was $125.6 million, compared to $96.6 million in the same period last year, an increase of 30%.

New Epocrates EDU Program Tops the Dean’s List (MarketWatch)
Epocrates, Inc. (NASDAQ:EPOC), an athenahealth, Inc (NASDAQ:ATHN) -8.53% company, today announced the launch of Epocrates EDU, a program created explicitly for medical education institutions seeking to provide all school-affiliated personnel universal access to clinical references. The program brings Epocrates, Inc. (NASDAQ:EPOC)’ premium mobile and online resources into the classroom, library and on rounds. …Epocrates, Inc. (NASDAQ:EPOC), an athenahealth, Inc (NASDAQ:ATHN), is recognized for developing the #1 medical application among U.S. physicians for clinical content, practice tools, and health industry engagement at the point of care.